NSE · Healthcare · Medical Care Facilities
EPS came in at 40.37 against a street estimate of 38.31 — a beat of 5.4%.
with an average price target of ₹9,836.50.
CONFIDENT Apollo delivered 21% consolidated revenue growth to ₹7,043 Cr with EBITDA margin expansion to 15.5%. Hospitals grew 22%, HealthCo 20%, AHLL 15%. Digital losses narrowing sharply; breakeven expected Q3 FY27. Q1 FY27 Demand broad-based across metros, Tier 1, Tier 2 markets. Bangladesh patient volumes recovered to ~60–70% of historical peak but with higher clinical complexity. International patients now 26% growth, representing 30% of oncology volumes. Analysts probed hospital growth sustainability (confirmed 18–20%), digital revenue-to-GMV disconnect (clarified consult vs. product economics), and pricing power amid political scrutiny (management defended 4% as medical inflation, not tariff inflation, backed by case complexity). Insurance breakeven timing became key credibility test. 2026-08-13…
Full summary in the app.
| Holder | Stake |
|---|---|
| SBI Nifty 50 ETF | 2.34% |
| Axis Mutual Fund Trustee | 1.77% |
| ICICI Prudential Balanced Advantage Fund | 1.58% |
| Government Pension Fund Global | 1.54% |
| HDFC Trustee Company | 1.48% |
| Document | Date |
|---|---|
| Annual report FY2026 | 2026-08-28 |
| Q1 FY27 earnings call APOLLO HOSPITALS ENTERPRISE LIMITED - DOCUMENT SUMMARY HEADLINE NUMBERS • Document is a regulatory filing dated August 19, 2026 announcing availabil | 2026-08-19 |
| Investor presentation · Q1 FY27 APOLLO HOSPITALS ENTERPRISE LIMITED — Q1 FY27 SUMMARY HEADLINE NUMBERS • Consolidated Revenue: ₹70,435 mio, up 21% YoY (vs ₹58,421 mio in Q1 FY26) • | 2026-08-12 |
| Quarterly results · Q1 FY27 APOLLO HOSPITALS ENTERPRISE LIMITED – FINANCIAL SUMMARY Board Meeting – August 12, 2026 --- HEADLINE NUMBERS • Q1 FY2026-27 (3 months ended June 30 | 2026-08-12 |
| Annual report FY2026 APOLLO HOSPITALS ENTERPRISE LIMITED — FINANCIAL SUMMARY FOR INVESTORS HEADLINE NUMBERS • Revenue from operations (FY 2025-26): ₹93,262 million (up 1 | 2026-08-01 |
| Q4 FY26 earnings call APOLLO HOSPITALS ENTERPRISE LIMITED - DOCUMENT SUMMARY DOCUMENT NATURE & AVAILABILITY • This is a regulatory disclosure notification dated May 25, 2 | 2026-05-25 |
| Quarterly results · Q4 FY26 APOLLO HOSPITALS ENTERPRISE LIMITED - FINANCIAL SUMMARY HEADLINE NUMBERS • FY2025-26 Revenue from Operations: Rs. 93,262 million (standalone), Rs. 2 | 2026-05-20 |
| Investor presentation APOLLO HOSPITALS ENTERPRISE LIMITED - Q4 FY26 EARNINGS SUMMARY HEADLINE NUMBERS • Consolidated Revenue Q4FY26: ₹66,055 million, up 18% YoY (Q4FY25: | 2026-05-20 |
Readable in the app.
| Action | Detail | Date |
|---|---|---|
| Dividend | ₹10 / share ex-date Aug 14, 2026 | 2026-08-14 |
| Dividend | ₹10 / share ex-date Feb 16, 2026 | 2026-02-16 |
| Announcement | Date |
|---|---|
| Amalgamation/Merger of Apollo Hospitals Enterprise Limited announced Apollo Hospitals Enterprise Limited has informed the Exchange about Amalgamation/Merger | 2026-05-20 |
Technicals, trade setups with a published hit rate, AI analysis and earnings-call summaries for Apollo Hospitals Enterprise Limited — free to start.
Open in the appGoogle PlayApp StoreData updated 2026-10-18.